PL

Plumbline Life Sciences, Inc.

Develops DNA-based therapeutics and vaccines for companion and farm animals.

222670 | KO

Overview

Corporate Details

ISIN(s):
KR7222670002
LEI:
Country:
South Korea
Address:
서울특별시 서초구 반포대로 222성의교정 성의회관 1315호, 서울특별시

Description

Plumbline Life Sciences, Inc. is an animal biopharmaceutical company that develops and manufactures drugs for animals based on an innovative DNA medicine platform technology. The company creates a new class of nucleic acid-based medicines that are designed to be potent, safe, and stable at room temperature, with a simplified manufacturing process. Its pipeline is focused on two primary areas: therapeutics for companion animals and vaccines for farm animals. A key product is 'RenewDog', a first-in-class DNA therapeutic developed for aging dogs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-10-22 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2024-10-15 00:00
[기재정정]기타주요경영사항(자율공시) (피엘에스D1000 동물용의약품 제조 품목허가 승인)
Korean 8.7 KB
2024-10-14 00:00
기타주요경영사항(자율공시) (피엘에스-D1000 동물용의약품 제조 품목허가 승인)
Korean 5.2 KB
2024-10-02 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2024-09-23 00:00
주요사항보고서(유상증자결정)
Korean 26.0 KB
2024-09-13 00:00
기업설명회(IR)개최
Korean 7.0 KB
2024-06-03 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2024-05-22 00:00
기업설명회(IR)개최
Korean 7.0 KB
2024-03-28 00:00
정기주주총회결과
Korean 26.1 KB
2024-03-28 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 8.3 KB
2024-03-28 00:00
주식매수선택권부여에관한신고
Korean 18.1 KB
2024-03-28 00:00
본점소재지변경
Korean 5.0 KB
2024-03-20 00:00
감사보고서제출
Korean 9.9 KB
2024-03-20 00:00
사업보고서 (2023.12)
Korean 293.0 KB
2024-03-13 00:00
주주총회소집결의
Korean 13.9 KB

Automate Your Workflow. Get a real-time feed of all Plumbline Life Sciences, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Plumbline Life Sciences, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Plumbline Life Sciences, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.